TapewireFind a company

organization · Reporting owner

GCGM Investment Holdings, LP

Disclosed activity across 4 companies

Tapewire entity
87375
SEC CIK
0001774568

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Evolv Technologies Holdings, Inc.EVLV · Entity 501710% ownerJuly 16, 2021July 26, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectBy General Catalyst Group V, L.P.12,774,845 Reported balance Holding disclosure · report date 2021-07-16 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 12,774,845

F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement.

F2: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Class A Common StockSEC Table I · non-derivativeIndirectBy GC Entrepreneurs Fund V, L.P.271,865 Reported balance Holding disclosure · report date 2021-07-16 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 271,865

F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement.

F3: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Class A Common StockSEC Table I · non-derivativeIndirectBy General Catalyst Group V, Supplemental, L.P.279,438 Reported balance Holding disclosure · report date 2021-07-16 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 279,438

F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement.

F4: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F5: (Continued from Footnote 5) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities

Performance RightsSEC Table II · derivative / convertible securityIndirectBy General Catalyst Group V, L.P.Not disclosed Reported balance Holding disclosure · report date 2021-07-16 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026.

F2: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Performance RightsSEC Table II · derivative / convertible securityIndirectBy GC Entrepreneurs Fund IV, L.P.Not disclosed Reported balance Holding disclosure · report date 2021-07-16 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance Not disclosed

F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026.

F3: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Performance RightsSEC Table II · derivative / convertible securityIndirectBy General Catalyst Group V, Supplemental, L.P.Not disclosed Reported balance Holding disclosure · report date 2021-07-16 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance Not disclosed

F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026.

F4: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F5: (Continued from Footnote 5) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person acquired a portion of these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement") and the other portion of these securities on July 16, 2021, pursuant to that certain Noteholders' Consent dated June 21, 2021, by and among the noteholders identified therein, NewHold Investments Corp. and Old Evolv, entered into in connection with the Merger Agreement.

F2: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

F3: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P. and GC Entrepreneurs Fund V, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

F4: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F5: (Continued from Footnote 5) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities

F6: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Section 16 reporting ended · disclosed 2021-03-02. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Series 1 Common StockSEC Table I · non-derivativeIndirectBy General Catalyst Group IV, L.P.2,531,821 Reported balance After 2021-02-26 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2021-02-26 · Other · Disposed 632,955 · Balance 2,531,821

F1: Effective February 26, 2021, General Catalyst Group IV, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 632,955 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F2: The reported securities are held directly by General Catalyst Group IV, L.P. General Catalyst GP IV, LLC is the general partner of General Catalyst Partners IV, L.P., which is the general partner of General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP IV, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Series 1 Common StockSEC Table I · non-derivativeIndirectBy GC Entrepreneurs Fund IV, L.P.67,176 Reported balance After 2021-02-26 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2021-02-26 · Other · Disposed 16,794 · Balance 67,176

F3: Effective February 26, 2021, GC Entrepreneurs Fund IV, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 16,794 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F4: The reported securities are held directly by GC Entrepreneurs Fund IV, L.P. General Catalyst GP IV, LLC is the general partner of General Catalyst Partners IV, L.P., which is the general partner of General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP IV, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Series 1 Common StockSEC Table I · non-derivativeIndirectBy General Catalyst Group V, L.P.1,361,295 Reported balance After 2021-02-26 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2021-02-26 · Other · Disposed 340,399 · Balance 1,361,295

F5: Effective February 26, 2021, General Catalyst Group V, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 340,399 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F6: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F7: (Continued from Footnote 6) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Series 1 Common StockSEC Table I · non-derivativeIndirectBy GC Entrepreneurs Fund V, L.P.81,865 Reported balance After 2021-02-26 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2021-02-26 · Other · Disposed 20,466 · Balance 81,865

F8: Effective February 26, 2021, GC Entrepreneurs Fund V, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 20,466 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F9: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F10: (Continued from Footnote 9) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Series 1 Common StockSEC Table I · non-derivativeIndirectBy General Catalyst Group V Supplemental, L.P.2,560,546 Reported balance After 2021-02-26 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 5 · 2021-02-26 · Other · Disposed 640,136 · Balance 2,560,546

F11: Effective February 26, 2021, General Catalyst Group V Supplemental, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 640,136 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F12: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F13: (Continued from Footnote 12) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Filing footnotes · ownership attribution and instrument terms

F1: Effective February 26, 2021, General Catalyst Group IV, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 632,955 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F2: The reported securities are held directly by General Catalyst Group IV, L.P. General Catalyst GP IV, LLC is the general partner of General Catalyst Partners IV, L.P., which is the general partner of General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP IV, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

F3: Effective February 26, 2021, GC Entrepreneurs Fund IV, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 16,794 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F4: The reported securities are held directly by GC Entrepreneurs Fund IV, L.P. General Catalyst GP IV, LLC is the general partner of General Catalyst Partners IV, L.P., which is the general partner of General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP IV, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

F5: Effective February 26, 2021, General Catalyst Group V, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 340,399 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F6: The reported securities are held directly by General Catalyst Group V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F7: (Continued from Footnote 6) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

F8: Effective February 26, 2021, GC Entrepreneurs Fund V, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 20,466 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F9: The reported securities are held directly by GC Entrepreneurs Fund V, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F10: (Continued from Footnote 9) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

F11: Effective February 26, 2021, General Catalyst Group V Supplemental, L.P., a venture capital partnership, distributed in-kind, without consideration, a total of 640,136 shares of Series 1 Common Stock of the Issuer to its general and limited partners.

F12: The reported securities are held directly by General Catalyst Group V Supplemental, L.P. General Catalyst GP V, LLC is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P. and General Catalyst Group V Supplemental, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP V, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., and General Catalyst Group V Supplemental, L.P. GCGM Investment Holdings, L.P. is a limited partner of General Catalyst Partners V, L.P. with a pecuniary interest in the reported securities.

F13: (Continued from Footnote 12) GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Livongo Health, Inc.

Report date October 30, 2020 · Filed November 03, 2020

Jointly reported with GC Venture LH Manager, LLC, GC Partners Holdings, LP, CHENAULT KENNETH I

Section 16 reporting ended · disclosed 2020-11-03. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote982,160 Reported balance After 2020-10-30 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2020-10-30 · Other · Acquired 7,922 · Balance 982,160

F1: On October 30, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 7,922 shares of the Issuer's Common Stock.

Common StockSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2020-10-30 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2020-10-30 · Other · Disposed 982,160 · Balance 0

F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.

F3: 17,933 shares were held by 7wire, and the balance were held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, shared voting and investment power with respect to shares held by 7wire and GC Group VIII LP.

Common StockSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2020-10-30 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2020-10-30 · Other · Disposed 653,918 · Balance 0

F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.

F4: The shares were held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.

Common StockSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2020-10-30 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2020-10-30 · Other · Disposed 2,892,681 · Balance 0

F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.

F5: The shares were held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Group VIII Supplemental.

Common StockSEC Table I · non-derivativeIndirectSee footnote0 Reported balance After 2020-10-30 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 5 · 2020-10-30 · Other · Disposed 13,943,216 · Balance 0

F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.

F6: The shares were held by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Group VI LP. GCGM Investment Holdings, L.P. is a limited partner of GC Group VI LP with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.

Filing footnotes · ownership attribution and instrument terms

F1: On October 30, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 7,922 shares of the Issuer's Common Stock.

F2: Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.

F3: 17,933 shares were held by 7wire, and the balance were held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, shared voting and investment power with respect to shares held by 7wire and GC Group VIII LP.

F4: The shares were held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.

F5: The shares were held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Group VIII Supplemental.

F6: The shares were held by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Group VI LP. GCGM Investment Holdings, L.P. is a limited partner of GC Group VI LP with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.

Section 16 reporting ended · disclosed 2024-09-19. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect0 Last balance in matching sequence After 2024-09-17 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2024-09-17 · Other · Disposed 2,998,022 · Balance 1,978

F1: Effective September 17, 2024, GC Venture VIII-B, LLC ("GCVVIIIB"), a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 2,998,022 shares of Class A Common Stock of the Issuer to its general and limited partners.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Row 2 · 2024-09-17 · Sale · Disposed 1,978 · Balance 0

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.4392 to $47.4391, inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Class A Common StockSEC Table I · non-derivativeIndirectDirectly held by GC Venture VIII-B Manager, LLC0 Last balance in matching sequence After 2024-09-17 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 3 · 2024-09-17 · Other · Acquired 185,926 · Balance 185,926

F6: Represents shares previously reported as held through GCVVIIIB.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Row 4 · 2024-09-17 · Other · Disposed 185,926 · Balance 0

F7: Effective September 17, 2024, GCVVIIIB Manager, a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 185,926 shares of Class A Common Stock of the Issuer to its general and limited partners.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Class A Common StockSEC Table I · non-derivativeIndirectDirectly held by GCGM Investment Holdings, LP0 Last balance in matching sequence After 2024-09-18 transaction · row 6 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 5 · 2024-09-18 · Other · Acquired 21,346 · Balance 21,346

F8: Represents shares previously reported as held through GCVVIIIB Manager.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Row 6 · 2024-09-18 · Sale · Disposed 21,346 · Balance 0

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.63 to $48.63, inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Class A Common StockSEC Table I · non-derivativeIndirectDirectly held by General Catalyst Group XI - Endurance, L.P.2,000,000 Reported balance Holding disclosure · report date 2024-09-17 · row 7 Holding and transaction disclosures are not merged.
1 source row

Row 7 · Balance 2,000,000

F10: GCGMH LLC is the general partner of GCGMH, which is the manager of GCGM LLC, which is the manager of General Catalyst Endurance GP XI, LLC, which is the general partner of General Catalyst Partners XI - Endurance, L.P., which is the general partner of General Catalyst Group XI - Endurance, L.P. Each party named above disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00IndirectDirectly held by General Catalyst Group VIII, L.P.11,187,815 Reported balance Holding disclosure · report date 2024-09-17 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 11,187,815

F11: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis.

Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct5,588,813 Reported balance Holding disclosure · report date 2024-09-17 · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · Balance 5,588,813

F11: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

Class B Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00IndirectDirectly held by General Catalyst Group X - Endurance, L.P.4,520,428 Reported balance Holding disclosure · report date 2024-09-17 · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · Balance 4,520,428

F11: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis.

Filing footnotes · ownership attribution and instrument terms

F1: Effective September 17, 2024, GC Venture VIII-B, LLC ("GCVVIIIB"), a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 2,998,022 shares of Class A Common Stock of the Issuer to its general and limited partners.

F2: General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of GCGM Investment Holdings, LP ("GCGM IH") and General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of General Catalyst Group Management, LLC ("GCGM LLC"), which is (a) the manager of GC Venture VIII-B Manager, LLC, which is the manager of GCVVIIIB, and (b) the manager of General Catalyst GP VIII, LLC ("GCGPVIII"), which is the general partner of General Catalyst Partners VIII, L.P. ("GCPVIII"), which is the general partner of General Catalyst Group VIII, L.P. ("GCGVIII"),

F3: (Continued from Footnote 2) and (d) the manager of General Catalyst GP X - Growth Venture, LLC, which is the general partner of General Catalyst Partners X - Growth Venture, L.P., which is the general partner of General Catalyst Group X - Endurance, L.P. ("GCGXE").

F4: (Continued from Footnote 3) Each party named above disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.4392 to $47.4391, inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.

F6: Represents shares previously reported as held through GCVVIIIB.

F7: Effective September 17, 2024, GCVVIIIB Manager, a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 185,926 shares of Class A Common Stock of the Issuer to its general and limited partners.

F8: Represents shares previously reported as held through GCVVIIIB Manager.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.63 to $48.63, inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.

F10: GCGMH LLC is the general partner of GCGMH, which is the manager of GCGM LLC, which is the manager of General Catalyst Endurance GP XI, LLC, which is the general partner of General Catalyst Partners XI - Endurance, L.P., which is the general partner of General Catalyst Group XI - Endurance, L.P. Each party named above disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F11: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 07, 2020 Filed Aug 11, 2020 18:06 UTC Commerce.com, Inc. BIGC · Entity 6337 ConversionSeries 1 Common Stock 3,628,722 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-022023 · doc4.xml · nonDerivative · entry 1

General Catalyst GP V, LLC · CIK 0001550975 · 10% owner

General Catalyst Partners V, L.P. · CIK 0001551791 · 10% owner

General Catalyst Group V LP · CIK 0001414929 · 10% owner

GC Entrepreneurs Fund V, LP · CIK 0001549857 · 10% owner

General Catalyst Group V Supplemental LP · CIK 0001414928 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By General Catalyst Group IV, LP

Disclosed balance after: 3,628,722

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, and Series F Preferred Stock (a) automatically converted into shares of the Issuer's Series 1 Common Stock at the applicable conversion ratio set forth in the Issuer's certificate of incorporation immediately prior to the completion of the Issuer's initial public offering of Series 1 Common Stock and (b) had no expiration date

F2 · ownership.nature: The reported securities are held directly by General Catalyst Group IV, L.P. General Catalyst GP IV, LLC is the general partner of General Catalyst Partners IV, L.P., which is the general partner of General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Lawrence Bohn, a member of Issuer's board of directors, Joel Cutler, and David Fialkow are managing directors of General Catalyst GP IV, LLC, and, as a result, may be deemed to have voting and dispositive power over the shares held by General Catalyst Group IV, L.P. and GC Entrepreneurs Fund IV, L.P. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 23:38 UTC Livongo Health, Inc. LVGO · Entity 145566 OtherCommon Stock 653,918 $0.00 $0.00
Disclosure

SEC source: 0001012975-20-000670 · edgar.xml · nonDerivative · entry 2

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 653,918

F4 · kind: As part of the distribution described in footnote 1, GC Venture LH Manager, LLC received 653,918 shares of the Issuer's Common Stock.

F5 · ownership.nature: The shares are held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja share voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities. Each reporting person and entity disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Read SEC document
July 29, 2020 Filed Jul 31, 2020 23:38 UTC Livongo Health, Inc. LVGO · Entity 145566 OtherCommon Stock 2,678,571 $0.00 $0.00
Disclosure

SEC source: 0001012975-20-000670 · edgar.xml · nonDerivative · entry 1

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · kind: GC Venture LH, LLC distributed these shares to its members on a pro rata basis for no consideration and no longer holds any shares.

F2 · ownership.nature: General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GC Venture LH Manager, LLC, which is the manager and a member of GC Venture LH, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to shares held by GC Venture LH, LLC. GCGM Investment Holdings, L.P. is a non managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.

F3 · ownership.nature: Each reporting person and entity disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Read SEC document
June 24, 2020 Filed Jun 27, 2020 01:41 UTC Livongo Health, Inc. LVGO · Entity 145566 OtherCommon Stock 3,907 Not disclosed Not disclosed
Disclosure

SEC source: 0001012975-20-000589 · edgar.xml · nonDerivative · entry 1

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 971,064

F1 · kind: On June 24, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P., were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., which is wholly owned by General Catalyst Group VIII, L.P., received 3,907 shares of the Issuer's Common Stock.

F2 · price: Pro rata distribution from a limited partnership of which the reporting person was a non-managing member.

F3 · ownership.nature: 6,837 shares are held by 7wire Investment Holdings, Ltd. and the balance are held by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to shares held by 7wire Investment Holdings, Ltd. and GC Group VIII LP. Each reporting person and entity disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.

Read SEC document
May 19, 2020 Filed May 19, 2020 21:25 UTC Livongo Health, Inc. LVGO · Entity 145566 OtherCommon Stock 131,939 $0.00 $0.00
Disclosure

SEC source: 0001012975-20-000488 · edgar.xml · nonDerivative · entry 3

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F4 · kind: Effective May 19, 2020, GP VI LP distributed in-kind, without consideration, a total of 131,939 shares of Common Stock of the Issuer to its limited partners.

F4 · ownership.nature: Effective May 19, 2020, GP VI LP distributed in-kind, without consideration, a total of 131,939 shares of Common Stock of the Issuer to its limited partners.

Read SEC document
May 15, 2020 Filed May 19, 2020 21:25 UTC Livongo Health, Inc. LVGO · Entity 145566 OtherCommon Stock 131,939 $0.00 $0.00
Disclosure

SEC source: 0001012975-20-000488 · edgar.xml · nonDerivative · entry 2

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 131,939

F3 · kind: Shares acquired through a distribution in-kind from GC Group VI LP by GP VI LP. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GP VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

F3 · ownership.nature: Shares acquired through a distribution in-kind from GC Group VI LP by GP VI LP. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GP VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
May 15, 2020 Filed May 19, 2020 21:25 UTC Livongo Health, Inc. LVGO · Entity 145566 OtherCommon Stock 2,000,000 $0.00 $0.00
Disclosure

SEC source: 0001012975-20-000488 · edgar.xml · nonDerivative · entry 1

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 13,943,216

F1 · kind: Effective May 15, 2020, shares of Common Stock of the Issuer held by General Catalyst Group VI, L.P. or GC Group VI LP, a venture capital partnership, distributed in-kind, without consideration, a total of 2,000,000 shares of Common Stock of the Issuer to its general and limited partners.

F2 · kind: The remaining securities are held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

F1 · ownership.nature: Effective May 15, 2020, shares of Common Stock of the Issuer held by General Catalyst Group VI, L.P. or GC Group VI LP, a venture capital partnership, distributed in-kind, without consideration, a total of 2,000,000 shares of Common Stock of the Issuer to its general and limited partners.

F2 · ownership.nature: The remaining securities are held by GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
May 11, 2020 Filed May 13, 2020 01:39 UTC Livongo Health, Inc. LVGO · Entity 145566 SaleCommon Stock 6,900 $54.00 $372,600.00
Disclosure

SEC source: 0001012975-20-000420 · edgar.xml · nonDerivative · entry 3

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,943,216

F3 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
May 11, 2020 Filed May 13, 2020 01:39 UTC Livongo Health, Inc. LVGO · Entity 145566 SaleCommon Stock 120,369 $53.24 $6,408,445.56
Disclosure

SEC source: 0001012975-20-000420 · edgar.xml · nonDerivative · entry 2

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 15,950,116

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.00 to $53.95, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
May 11, 2020 Filed May 13, 2020 01:39 UTC Livongo Health, Inc. LVGO · Entity 145566 SaleCommon Stock 172,731 $52.59 $9,083,923.29
Disclosure

SEC source: 0001012975-20-000420 · edgar.xml · nonDerivative · entry 1

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 16,070,485

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.00 to $52.99, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionSeries E Convertible Preferred Stock · Derivative 2,892,681 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · derivative · entry 10

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 2,892,681 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F6 · derivative.exercise_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F6 · derivative.expiration_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F8 · ownership.nature: The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja share voting and investment power with respect to the shares held by GC Group VIII Supplemental. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionSeries E Convertible Preferred Stock · Derivative 964,227 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · derivative · entry 9

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 964,227 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F6 · derivative.exercise_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F6 · derivative.expiration_date: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F7 · ownership.nature: The shares are held of record by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja share voting and investment power with respect to the shares held by GC Group VIII LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionSeries D Convertible Preferred Stock · Derivative 2,242,655 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · derivative · entry 8

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 2,242,655 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F5 · price: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F5 · derivative.exercise_date: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F5 · derivative.expiration_date: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hement Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionSeries C Convertible Preferred Stock · Derivative 1,125,517 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · derivative · entry 7

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,125,517 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F4 · price: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F4 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F4 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hement Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionSeries B Convertible Preferred Stock · Derivative 446,747 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · derivative · entry 6

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 446,747 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F3 · price: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F3 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F3 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hement Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionSeries A Convertible Preferred Stock · Derivative 9,271,910 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · derivative · entry 5

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 9,271,910 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hement Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 PurchaseCommon Stock 2,678,571 $28.00 $74,999,988.00
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · nonDerivative · entry 4

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,678,571

F9 · ownership.nature: The shares are held of record by GC Venture LH, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC, which is the manager of GC Venture LH, LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja share voting and investment power with respect to the shares held by GC Venture LH, LLC. GCGM Investment Holdings, L.P. is a non managing member of GC Venture LH Manager with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings with a pecuniary interested in the reported securities. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionCommon Stock 2,892,681 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · nonDerivative · entry 3

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,892,681

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F8 · ownership.nature: The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja share voting and investment power with respect to the shares held by GC Group VIII Supplemental. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionCommon Stock 964,227 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · nonDerivative · entry 2

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 964,227

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · price: Each share of Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F7 · ownership.nature: The shares are held of record by General Catalyst Group VIII, L.P., or GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja share voting and investment power with respect to the shares held by GC Group VIII LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document
July 29, 2019 Filed Aug 1, 2019 00:25 UTC Livongo Health, Inc. LVGO · Entity 145566 ConversionCommon Stock 13,086,829 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020757 · doc4.xml · nonDerivative · entry 1

GC Venture LH Manager, LLC · CIK 0001782658 · 10% owner

GC Venture LH, LLC · CIK 0001782659 · 10% owner

GCGM Investment Holdings, LP · CIK 0001774568 · 10% owner

GC Partners Holdings, LP · CIK 0001774569 · 10% owner

CHENAULT KENNETH I · CIK 0001180524 · 10% owner

Cutler Joel E · CIK 0001337122 · 10% owner

Fialkow David P · CIK 0001337220 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 16,243,216

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F3 · price: Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F4 · price: Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F5 · price: Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date.

F2 · ownership.nature: The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hement Taneja, a director of the Issuer, share voting and investment power with respect to the shares held by GC Group VI LP. Each of the reporting persons and entities disclaims beneficial ownership of the reported securities (except to the extent of such person's or entity's pecuniary interest in such securities).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.